Despite approval from Health Canada, delay in cancer drug funding leaves patients in limbo
- Posted on June 30, 2026
- By The Globe and Mail
- 0 Views
- 1 min read
Despite approval from Health Canada, delay in cancer drug funding leaves patients in limbo
A bespoke treatment for metastatic melanoma is unavailable to Canadians because it is still being reviewed for public funding
